Drug Profile
NV 1020
Alternative Names: NV1020; oHSV - MediGeneLatest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator MediGene Inc
- Developer Catherex
- Class Antineoplastics; Immunotherapies; Oncolytic viruses
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Liver cancer